Work

A Phase I Study of a New Nucleoside Analogue, OSI-7836, Using Two Administration Schedules in Patients with Advanced Solid Malignancies

Year: 2006

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-05-1932

Authors: Chooi P. Lee, Maja J.A. de Jonge, Anne E. O'Donnell, Kristel L. Schothorst, Janet Hanwell, Jon B. Chick, Rik A. Brooimans, Laurel M. Adams, Daniel W. Drolet, Johann S. de Bono, Stan B. Kaye, Ian R. Judson, Jaap Verweij

Institutions: Royal Marsden Hospital, Erasmus MC, State of Colorado

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

OpenAlex ID: W2162971711

FWCI: 0.408

Cites: 24

Cited by: 8

Related to: 10